DBV Technologies S.A. — Major Shareholding Notification 2025

Oct 14, 2025

xml version="1.0" encoding="UTF-8"? SCHEDULE 13G Field: Pseudo-Tag; ID: Name; Data: Invus Global Management, LLC 0002005369 XXXXXXXX LIVE Ordinary Shares, nominal value Euro 0.10 per share 10/06/2025 0001613780 DBV Technologies S.A. 23306J309 107 avenue de la Republique Chatillon I0 92320 Rule 13d-1(c) Invus Public Equities, L.P. D0 10438485.00 0.00 10438485.00 0.00 10438485.00 N 7.0 PN Invus Public Equities, L.P. holds an aggregate of 2,087,697 American Depositary Shares ("ADSs"), each of which ADS represents five Ordinary Shares, nominal value Euro 0.10 per share, totaling 10,438,485 Ordinary Shares of the Issuer. Invus Public Equities Advisors, LLC DE 10438485.00 0.00 10438485.00 0.00 10438485.00 N 7.0 OO Invus Public Equities, L.P. holds an aggregate of 2,087,697 American Depositary Shares ("ADSs"), each of which ADS represents five Ordinary Shares, nominal value Euro 0.10 per share, totaling 10,438,485 Ordinary Shares of the Issuer. Invus Global Management, LLC DE 10438485.00 0.00 10438485.00 0.00 10438485.00 N 7.0 OO Invus Public Equities, L.P. holds an aggregate of 2,087,697 American Depositary Shares ("ADSs"), each of which ADS represents five Ordinary Shares, nominal value Euro 0.10 per share, totaling 10,438,485 Ordinary Shares of the Issuer. Siren, L.L.C. DE 10438485.00 0.00 10438485.00 0.00 10438485.00 N 7.0 OO Invus Public Equities, L.P. holds an aggregate of 2,087,697 American Depositary Shares ("ADSs"), each of which ADS represents five Ordinary Shares, nominal value Euro 0.10 per share, totaling 10,438,485 Ordinary Shares of the Issuer. Avicenna Life Sci Master Fund LP E9 1099975.00 0.00 1099975.00 0.00 1099975.00 N 0.7 PN Avicenna Life Sci Master Fund LP holds an aggregate of 219,995 American Depositary Shares ("ADSs"), each of which ADS represents five Ordinary Shares, nominal value Euro 0.10 per share, totaling 1,099,975 Ordinary Shares of the Issuer. Avicenna Life Sci Master GP LLC DE 1099975.00 0.00 1099975.00 0.00 1099975.00 N 0.7 OO Avicenna Life Sci Master Fund LP holds an aggregate of 219,995 American Depositary Shares ("ADSs"), each of which ADS represents five Ordinary Shares, nominal value Euro 0.10 per share, totaling 1,099,975 Ordinary Shares of the Issuer. Ulys, L.L.C. DE 1099975.00 0.00 1099975.00 0.00 1099975.00 N 0.7 OO Avicenna Life Sci Master Fund LP holds an aggregate of 219,995 American Depositary Shares ("ADSs"), each of which ADS represents five Ordinary Shares, nominal value Euro 0.10 per share, totaling 1,099,975 Ordinary Shares of the Issuer. Raymond Debbane R1 11538460.00 0.00 11538460.00 0.00 11538460.00 N 7.8 IN Invus Public Equities, L.P. holds an aggregate of 2,087,697 American Depositary Shares ("ADSs") and Avicenna Life Sci Master Fund LP holds an aggregate of 219,995 ADSs, each of which ADS represents five Ordinary Shares, nominal value Euro 0.10 per share, totaling 11,538,460 Ordinary Shares of the Issuer. DBV Technologies S.A. 107 avenue de la Republique, 92320 Chatillon France See Item 2(c) below. See Item 2(c) below. (i) Invus Public Equities, L.P. ("Invus Public Equities") 750 Lexington Avenue, 30th Floor, New York, NY 10022 Citizenship: Bermuda limited partnership (ii) Invus Public Equities Advisors, LLC ("Invus PE Advisors") 750 Lexington Avenue, 30th Floor, New York, NY 10022 Citizenship: Delaware limited liability company (iii) Invus Global Management, LLC ("Global Management") 750 Lexington Avenue, 30th Floor, New York, NY 10022 Citizenship: Delaware limited liability company (iv) Siren, L.L.C. ("Siren") c/o The Invus Group, LLC, 750 Lexington Avenue, 30th Floor, New York, NY 10022 Citizenship: Delaware limited liability company (v) Avicenna Life Sci Master Fund LP ("Avicenna Fund") 750 Lexington Avenue, 30th Floor, New York, NY 10022 Citizenship: Cayman Islands limited partnership (vi) Avicenna Life Sci Master GP LLC ("Avicenna GP") 750 Lexington Avenue, 30th Floor, New York, NY 10022 Citizenship: Delaware limited liability company (vii) Ulys, L.L.C. ("Ulys") 750 Lexington Avenue, 30th Floor, New York, NY 10022 Citizenship: Delaware limited liability company (viii) Mr. Raymond Debbane 750 Lexington Avenue, 30th Floor, New York, NY 10022 Citizenship: Panama The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." Y As of October 10, 2025, Invus Public Equities beneficially held 10,438,485 Ordinary Shares represented by an aggregate of 2,087,697 American Depositary Shares directly held by Invus Public Equities and Avicenna Fund beneficially held 1,099,975 Ordinary Shares represented by an aggregate of 219,995 American Depositary Shares directly held by Avicenna. Invus PE Advisors, as the general partner of Invus Public Equities, controls Invus Public Equities and, accordingly, may be deemed to beneficially own the Ordinary Shares directly held by Invus Public Equities. Global Management, as the managing member of Invus PE Advisors, controls Invus PE Advisors and, accordingly, may be deemed to beneficially own the Ordinary Shares that Invus PE Advisors may be deemed to beneficially own. Siren, as the managing member of Global Management, controls Global Management and, accordingly, may be deemed to beneficially own the Ordinary Shares that Global Management may be deemed to beneficially own. Avicenna GP, as the general partner of Avicenna Fund, controls Avicenna Fund and, accordingly, may be deemed to beneficially own the Ordinary Shares beneficially held by Avicenna Fund. Ulys, as the managing member of Avicenna GP, controls Avicenna GP and, accordingly, may be deemed to beneficially own the Ordinary Shares that Avicenna GP may be deemed to beneficially own. Mr. Raymond Debbane, as the managing member of Siren and Ulys, controls Siren and Ulys and, accordingly, may be deemed to beneficially own the Ordinary Shares that Siren and Ulys may be deemed to beneficially own. As of October 10, 2025, each of the Reporting Persons may be deemed to be the beneficial owner of the percentage of Ordinary Shares listed on such Reporting Person's cover page. Calculations of the percentage of Ordinary Shares beneficially owned are based on 148,513,619 Ordinary Shares outstanding as reported in the Issuer's press release dated October 6, 2025. See each cover page hereof. See each cover page hereof. See each cover page hereof. See each cover page hereof. Y Y Y Y Y N Each of the Reporting Persons hereby makes the following certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Invus Public Equities, L.P. /s/ Raymond Debbane Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner 10/10/2025 Invus Public Equities Advisors, LLC /s/ Raymond Debbane Raymond Debbane, President 10/10/2025 Invus Global Management, LLC /s/ Raymond Debbane Raymond Debbane, President 10/10/2025 Siren, L.L.C. /s/ Raymond Debbane Raymond Debbane, President 10/10/2025 Avicenna Life Sci Master Fund LP /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner 10/10/2025 Avicenna Life Sci Master GP LLC /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer 10/10/2025 Ulys, L.L.C. /s/ Raymond Debbane Raymond Debbane, President 10/10/2025 Raymond Debbane /s/ Raymond Debbane Raymond Debbane 10/10/2025